1 / 11

Essential Medicines for Children in India

Essential Medicines for Children in India. Gitanjali Batmanabane MD PhD Technical Officer - Essential Medicines & Other Drugs World Health Organization Regional Office for South-East Asia New Delhi. Overview of BMC-India. What was the problem we were trying to resolve?

mariel
Download Presentation

Essential Medicines for Children in India

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Essential Medicines forChildren in India Gitanjali Batmanabane MD PhD Technical Officer - Essential Medicines & Other Drugs World Health Organization Regional Office for South-East Asia New Delhi

  2. Overview of BMC-India • What was the problem we were trying to resolve? • How did we get started? • What processes are we using? What have we done? • What are our most important current challenges? • Where did we get stuck?

  3. What was the problem we were trying to resolve? Highest number of children dying before their fifth birthday 3 die/minute – neonatal sepsis, diarrhoea, pneumonia Too many medicines Quality may be an issue Medicines widely available Cheap Most parts of the country are well connected Health systems are in place Procurement systems are in place

  4. How did we get started? • Selection of states • Chhattisgarh & Orissa chosen • Poor health statistics • EMLs of the two states were analysed • Very little children’s medicines on the list • National EML • Mistakes, very few children’s medicines, not current (2003)

  5. What was planned • National level activity • Preparation of EMLc by the Indian Academy of Paediatrics • State level activities (Chhattisgarh & Orissa) • Conduct pricing and availability surveys • Prepare a state EMLc

  6. What processes are we using? • Selected a professional body – expertise, many key opinion leaders, ownership, advocacy • All basic documents were given – group of members received background information at a two day consultation • First draft prepared and presented – feedback given • Revised many times over

  7. What processes are we using? • Selected a team in each state – which had experience and previous training • Report of the comparison of the state EML with WHO Model EMLc was given to the team • Word document template of WHO Model EMLc given • First draft prepared and presented – feedback given

  8. What has been done? • National level activity • Preparation of EMLc by the Indian Academy of Paediatrics • State level activities • Conduct pricing and availability surveys • Prepare a state EMLc Final draft stage of the IAP EMLc Baseline pricing and availability surveys done State EMLs have been prepared

  9. What are the current challenges? • Getting permissions – time, delegation of responsibility, signature of govt. officials • Communication – contacting PI • Budget - under or over estimate • Report writing • Quality of data, quality of the EMLc

  10. Where did we get stuck? • Preparation of EMLs – concept & principles of selection • Professional bodies – the EML is no one’s baby • Even if EML is ready – procurement is a long way off • Ethics clearances, financial issues (bank account) • Post survey refractory period

  11. Thank you

More Related